Medical News

RSS

Cancer could be broken down by its evolving defense mechanism

Turning the tables, Katherine Borden at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) has evoked Star Trek's Borg in her fight against the disease.

24 Dec 2014

It's too early to know health effects of e-cigarettes

Cigarettes have been convicted of many crimes over the years. But the jury's still out on whether their younger, more fashionable cousins - electronic cigarettes, or e-cigarettes - will meet the same fate.

24 Dec 2014

Whole-genome sequencing can identify patients' risk for hereditary cancer

UT Southwestern Medical Center cancer researchers have demonstrated that whole-genome sequencing can be used to identify patients' risk for hereditary cancer, which can potentially lead to improvements in cancer prevention, diagnosis, and care.

24 Dec 2014

Innovative software predicts sudden cardiac death in patients at risk of arrhythmia

At Galway Hospital, in Ireland, a device is currently used to "predict" cardiac events in people at risk of sudden cardiac death.

24 Dec 2014

Comprehensive care improves health of high-risk, chronically ill children, reduces hospital costs

High-risk children with chronic illness who received care at a clinic that provided both primary and specialty care and features to promote prompt effective care had an increase in access to care and parent satisfaction and a reduction in serious illnesses and costs, according to a study in the December 24/31 issue of JAMA.

24 Dec 2014

Unauthorized weight loss product seized from two retail locations in southwest of Calgary

The unauthorized product "Hydro-Lean" was seized from two Calgary stores because the label indicates it contains a combination of ingredients that can cause serious health risks (ephedrine and caffeine).

23 Dec 2014

Next generation sequencing in malignant pleural mesothelioma tumors reveals complex mutational setting

Next generation sequencing in malignant pleural mesothelioma (MPM) tumors shows a complex mutational setting with a high number of genetic alterations in genes involved in DNA repair, cell survival and cell proliferation pathways. Increased accumulation of mutations correlates with early progression of the tumor and decreased survival.

23 Dec 2014

Kaiser Permanente receives five 2014 eHealthcare Leadership Awards

Kaiser Permanente has received five 2014 eHealthcare Leadership Awards, including one of only five organizations to receive the highest honor for eHealth Organizational Commitment.

23 Dec 2014

PTC begins rolling NDA submission for Translarna to treat nmDMD

PTC Therapeutics, Inc. today announced that it has commenced a rolling submission of a New Drug Application to the United States Food and Drug Administration for Translarna™ for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD).

23 Dec 2014

AMIC files de novo submission with FDA for Y-90 RadioGel device, seeks Class II reclassification

Advanced Medical Isotope Corporation, a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that it has filed a de novo submission with the Food and Drug Administration for marketing clearance for its patented Y-90 RadioGel(TM) device pursuant to Section 513(f)(2) of the U.S. Food, Drug and Cosmetic Act.

23 Dec 2014

Mirati begins dosage in MGCD265 Phase 1b clinical trial for NSCLC

Mirati Therapeutics, Inc. today announced that the first patient with Non-Small Cell Lung Cancer (NSCLC) has been dosed in a Phase 1b clinical trial of MGCD265 in selected patients exhibiting genetic alterations of MET or Axl.

23 Dec 2014

EMA validates Synageva's sebelipase alfa MAA for LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, today announced validation by the European Medicines Agency of the Marketing Authorization Application for sebelipase alfa for LAL Deficiency.

23 Dec 2014

CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, announced today the first signed Middle East sales/distribution agreement for lead product Neutrolin with distributor Arabian Trade House in the Kingdom of Saudi Arabia.

23 Dec 2014

Radiation/chemotherapy increases risk of leukemia in early-stage breast cancer patients

The risk of developing leukemia after radiation therapy or chemotherapy for early stage breast cancer remains very small, but it is twice as high as previously reported, according to results of a new study led by researchers at the Johns Hopkins Kimmel Cancer Center.

23 Dec 2014

Conference raises concerns regarding lack of scientific data on products containing botanicals

The challenges related to assessing the safety of botanicals in foods and food supplements and regulating their use were highlighted at a conference held in Denmark in November 2014.

23 Dec 2014

Phagelux acquires biodegradable polymer delivery systems from Iveria Technologies

Phagelux, Inc., a leading anti-bacterial company developing phage-based solutions, is pleased to announce the acquisition of several biodegradable polymer delivery systems from Iveria Technologies, Inc., a U.S.-based development company specializing in such technologies.

23 Dec 2014

Shandong Taibang Biological Products earns GMP certification for new production facility

China Biologic Products, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd., has received Good Manufacturing Practices ("GMP") certification from the China Food and Drug Administration (the "CFDA") for its new coagulation factor production facility.

23 Dec 2014

IGI Laboratories submits three additional ANDAs to FDA

IGI Laboratories, Inc., a New Jersey based specialty generic pharmaceutical company, today announced it has submitted three additional abbreviated new drug applications (ANDAs) to the U.S. Food and Drug Administration (FDA), which brings the Company's total number of ANDA submissions in 2014 to eleven, with twenty-two submissions now pending at the FDA.

23 Dec 2014

People urged to seek healthy eating information from registered dietitian nutritionists

For many people, the New Year is an opportunity for a fresh look at life - a time to resolve to return to or even begin a healthy lifestyle.

23 Dec 2014

EB Pharma licenses tipifarnib from Janssen to study potential new therapy for HDV

EB Pharma, LLC., a subsidiary of Eiger BioPharmaceuticals, Inc., announced that it has executed an agreement with Janssen Pharmaceutica NV, for an exclusive license, to tipifarnib in the field of virology and a related, clinical stage back-up compound.

23 Dec 2014

Medical News

Cancer could be broken down by its evolving defense mechanism

It's too early to know health effects of e-cigarettes

Whole-genome sequencing can identify patients' risk for hereditary cancer

Innovative software predicts sudden cardiac death in patients at risk of arrhythmia

Comprehensive care improves health of high-risk, chronically ill children, reduces hospital costs

Unauthorized weight loss product seized from two retail locations in southwest of Calgary

Next generation sequencing in malignant pleural mesothelioma tumors reveals complex mutational setting

Kaiser Permanente receives five 2014 eHealthcare Leadership Awards

PTC begins rolling NDA submission for Translarna to treat nmDMD

AMIC files de novo submission with FDA for Y-90 RadioGel device, seeks Class II reclassification

Mirati begins dosage in MGCD265 Phase 1b clinical trial for NSCLC

EMA validates Synageva's sebelipase alfa MAA for LAL Deficiency

CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

Radiation/chemotherapy increases risk of leukemia in early-stage breast cancer patients

Conference raises concerns regarding lack of scientific data on products containing botanicals

Phagelux acquires biodegradable polymer delivery systems from Iveria Technologies

Shandong Taibang Biological Products earns GMP certification for new production facility

IGI Laboratories submits three additional ANDAs to FDA

People urged to seek healthy eating information from registered dietitian nutritionists

EB Pharma licenses tipifarnib from Janssen to study potential new therapy for HDV

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News